6. パーキンソン病 Parkinson disease Clinical trials / Disease details


臨床試験数 : 2,298 薬物数 : 2,202 - (DrugBank : 350) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 202

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05109364
(ClinicalTrials.gov)
November 23, 202113/10/2021Terazosin and Parkinson's Disease Extension StudyThe Effect of alpha1- Adrenergic Receptor Antagonist Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's Disease: A Follow up StudySymptomatic Parkinson Disease;REM Sleep Behavior Disorder;Pre-motor Parkinson's DiseaseDrug: Terazosin therapyCedars-Sinai Medical CenterNULLNot yet recruiting25 Years85 YearsAll15Phase 2NULL
2NCT04386317
(ClinicalTrials.gov)
November 1, 202024/4/2020Terazosin Effect on Cardiac Changes in Early Parkinson's DiseaseThe Effect of a1- Adrenergic Receptor Antagonist Therapy on Cardiac and Striatal Transporter Uptake in Pre-Motor and Symptomatic Parkinson's DiseaseREM Sleep Behavior Disorder;Pre-motor Parkinson's Disease;Symptomatic Parkinson DiseaseDrug: TerazosinCedars-Sinai Medical CenterNULLRecruiting25 Years85 YearsAll15Phase 2United States
3NCT03905811
(ClinicalTrials.gov)
September 24, 20191/4/2019Terazosin for Parkinson's DiseaseA Pilot Study of Terazosin for Parkinson's DiseaseParkinson DiseaseDrug: Terazosin 5 MG;Drug: Placebo oral capsuleJordan SchultzUniversity of IowaCompleted40 Years90 YearsAll13Phase 1/Phase 2United States